Experienced leadership across medical devices, neuroscience and commercialization
Cortigent’s leadership team and board bring experience in neurotechnology, product development, commercialization, finance and public-company governance.
Leadership
Executive Leadership
Hover over or select a profile to learn more about each leader’s experience.
Jonathan Adams, MBA
Chief Executive Officer, Director*
Medical-device and drug-technology commercialization, finance, marketing and public-company experience.
View experience
Jonathan Adams, MBA
Chief Executive Officer, Director*
- 35+ years of experience in drug and device technology commercialization, finance, marketing, sales and new product launches
- Founded BioVie Inc. and up-listed the company to Nasdaq in 2020
Jerry Culp
Chief Technical Officer
Global medical-device development and new-product platform leadership, including prior work at Stryker.
View experience
Jerry Culp
Chief Technical Officer
- Former VP of Global Development for Stryker and GM, Incubation of Medical Technology business
- Developed multiple new product platforms generating billions of dollars in revenues
John Bowers, MBA
Director*
Medical-device commercialization and leadership experience, including prior service at Northstar Neuroscience.
View experience
John Bowers, MBA
Director*
- Former CEO, Northstar Neuroscience, Inc.
- Former CCO, Verathon Medical, and SVP, SonoSite
- Commercialized cardiovascular and other devices
Company operations
Operational Leadership
Uday Patel, PhD
Lead Neuroscientist
Long-term Cortigent and Second Sight experience in complex neurological devices and neuro-engineering.
View experience
Uday Patel, PhD
Lead Neuroscientist
- 17 years at Cortigent and Second Sight
- Deep experience in complex neurological devices
- PhD from UCLA in neuroscience and neuro-engineering
Don Malackowski
Senior Product Development Consultant
Electronics design and medical-device development experience, including decades at Stryker.
View experience
Don Malackowski
Senior Product Development Consultant
- Former VP R&D at Stryker for 26 years, with nine years at prior startups
- Specializes in electronics design and medical device development
- 100+ U.S. patents with more pending
Governance
Board of Directors*
Adam Mendelsohn is Cortigent’s current sole director. The appointments of Jonathan Adams, John Bowers, Eric Robinson and Linda Szyper as directors are pending the merger closing.
Adam Mendelsohn, PhD
Chair
Medical-device entrepreneur and executive leadership experience.
View experience
Adam Mendelsohn, PhD
Chair
- Chief Executive Officer and Director of Vivani Medical Inc.
- Co-founder of Nano Precision Medical, predecessor to Vivani
- Technical Advisor to the Alfred E. Mann Institute for Biomedical Engineering
Eric Robinson, JD
Director*
Corporate legal and public-company board experience.
View experience
Eric Robinson, JD
Director*
- VP Legal Affairs, Our Rescue
- Chairman and Audit Committee Chair of ClearOne, Inc. (Nasdaq: CLRO)
- 33 years in private practice as a corporate attorney
Linda Szyper, MBA
Director*
Healthcare commercialization and operating leadership experience.
View experience
Linda Szyper, MBA
Director*
- Former Chief Operating Officer of McCann Health
- Former Chief Commercial Officer at Circassia Pharmaceuticals
- Former Chief Development Officer for Publicis Healthcare
* Establishing the Board of Directors is subject to the merger closing.
Corporate governance
Explore Cortigent’s board committees, committee charters and governance documents.